ArticleCancer research2017
Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.
Abstract read
In one paragraph
Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 30 citations in OpenAlex.
- Fluorescein-stained confocal laser endomicroscopy versus conventional frozen section for intraoperative histopathological assessment of intracranial tumors.Neuro-oncology · 2024Trial
- Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction Models.JACC. Basic to translational science · 2023Article
- PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach.Frontiers in nuclear medicine · 2023Review
- Tumor microenvironment and fibroblast activation protein inhibitor (FAPI) PET: developments toward brain imaging.Frontiers in nuclear medicine · 2023Review
- TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model.International journal of molecular sciences · 2022Article
- Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials.Journal of personalized medicine · 2022Review
- DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy.Cancers · 2022Review
- Magnetic Resonance Imaging-Guided Focused Ultrasound-Based Delivery of Radiolabeled Copper Nanoclusters to Diffuse Intrinsic Pontine Glioma.ACS applied nano materials · 2020Article
- Targeted Brain Tumor Radiotherapy Using an Auger Emitter.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020Article
- Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance.Fluids and barriers of the CNS · 2020Article
- Approaches to PET Imaging of Glioblastoma.Molecules (Basel, Switzerland) · 2020Review
- Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy.Frontiers in pharmacology · 2020Review
- Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas.Frontiers in oncology · 2019Article
- PARP-1-Targeted Radiotherapy in Mouse Models of Glioblastoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018Article
- Discriminating radiation injury from recurrent tumor with [EJNMMI research · 2018Article
- Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.Proceedings of the National Academy of Sciences of the United States of America · 2017Article
- Positron emission tomography imaging in diffuse intrinsic pontine glioma.Annals of translational medicine · 2017Article
- Molecular Imaging of PARP.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017Review
- Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[Nuclear medicine and biologyArticle
- Preclinical and first-in-human-brain-cancer applications of [Neuro-oncology advancesArticle
Corrections and comments
- Commented on by
Authors and funding
12 authors at 2 institutions in 1 country.
Susanne KossatzDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Brandon CarneyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Melanie SchweitzerDepartment of Neurological Surgery, Weill Cornell Medical College, New York, New York.
Giuseppe CarlucciDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Vesselin Z MiloushevDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Uday B MaachaniDepartment of Neurological Surgery, Weill Cornell Medical College, New York, New York.
Prajwal RajappaDepartment of Neurological Surgery, Weill Cornell Medical College, New York, New York.
Kayvan R KeshariDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
David PisapiaDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York.
Wolfgang A WeberDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Mark M SouweidaneDepartment of Neurological Surgery, Weill Cornell Medical College, New York, New York.
Thomas ReinerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. reinert@mskcc.org.
Memorial Sloan Kettering Cancer Center · USCornell University · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MRadioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and TherapyR01CA204441 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PILLARSETTY, NAGAVARAKISHORE · 2016 to 2020
$2.9MPET/MRI to study nanotherapy in atherosclerosisR01HL125703 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, WILLEM · 2015 to 2018
$2.4MBioorthogonal Strategies for Targeted PET Imaging Probe DevelopmentK25EB016673 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI REINER, THOMAS · 2013 to 2015
$525kDevelopment of Nuclear Auger Emitters for Targeted RadiotherapyR21CA191679 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI REINER, THOMAS, WEBER, WOLFGANG · 2015 to 2016
$187kNCI NIH HHS P30 CA008748NCI NIH HHS R01 CA204441NCI NIH HHS R21 CA191679NHLBI NIH HHS R01 HL125703NIBIB NIH HHS K25 EB016673
Abstract
Diffuse intrinsic pontine glioma (DIPG) is a childhood brainstem tumor with a universally poor prognosis. Here, we characterize a positron emission tomography (PET) probe for imaging DIPG
Indexed as
AnimalsBiomarkers, TumorBrain Stem NeoplasmsChickensDisease Models, AnimalFormaldehydeGliomaHumansMagnetic Resonance ImagingMiceParaffin EmbeddingPoly (ADP-Ribose) Polymerase-1Positron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsTissue FixationBiomarkers, TumorFormaldehydePARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Radiopharmaceuticals
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.